SalA modulates the mir-212-3p/SOX7 axis to activate the Wnt/β-catenin pathway, thereby ameliorating brain injury, edema, and neurological deficits induced by cerebral ischemia/reperfusion injury (CIRI), and providing a novel therapeutic approach and strategy for ischemic brain injury. This evidence concerns the gene SOX7 and Cerebral ischemia.